Methylpentylaminopropylidenebisphosphonate (BM 21.0955): a new potent and safe bisphosphonate for the treatment of cancer-associated hypercalcemia (Q72634899)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 August 1993

Language	Label	Description	Also known as
English	Methylpentylaminopropylidenebisphosphonate (BM 21.0955): a new potent and safe bisphosphonate for the treatment of cancer-associated hypercalcemia	scientific article published on 01 August 1993

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251767%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Methylpentylaminopropylidenebisphosphonate (BM 21.0955): a new potent and safe bisphosphonate for the treatment of cancer-associated hypercalcemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251767%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

C Wüster

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251767%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

K H Schöter

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251767%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

D Thiébaud

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251767%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

C Manegold

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251767%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

D Krahl

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251767%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

M R Clemens

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251767%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

M Ghielmini

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251767%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

P Jaeger

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251767%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

S H Scharla

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251767%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

publication date

1 August 1993

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251767%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Bone and Mineral

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251767%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251767%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251767%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

77-85

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251767%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980219-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980219-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A single-day treatment of tumor-induced hypercalcemia by intravenous amino-hydroxypropylidene bisphosphonate

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980219-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of acute hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980219-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response in the treatment of hypercalcemia of malignancy by a single infusion of the bisphosphonate AHPrBP

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980219-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clodronate in hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980219-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980219-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980219-X

7 January 2021

based on heuristic

inferred from DOI database lookup

BM 21.0955, a potent new bisphosphonate to inhibit bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980219-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The acute-phase response after bisphosphonate administration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980219-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Levels of parathyroid hormone-related protein (PTHrP) in hypercalcemia of malignancy are not lowered by treatment with the bisphosphonate BM 21.0955

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980219-X

7 January 2021

based on heuristic

inferred from DOI database lookup

APD in Paget's disease of bone. Role of the mononuclear phagocyte system?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980219-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-6009(08)80219-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251767%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8251767%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q72634899&oldid=2239311603"